Comparison the Long-Term Clinical Outcomes between Non Anti-TNF Versus Anti-TNF in RA Patients Who Failed to a First Anti-TNF

被引：0
|
作者：
Bogas, Patricia [1 ]
Plasencia-Rodriguez, Chamaida [1 ]
Balsa, Alejandro [1 ]
Navarro-Compan, Victoria [2 ]
Bonilla, Gema [1 ]
Moral Coro, Enrique [1 ]
Tornero, Carolina [1 ]
Nuno, Laura [1 ]
Peiteado, Diana [3 ]
机构：
[1] Hosp Univ La Paz, Madrid, Spain
[2] Hosp Univ La Paz, Rheumatol, Madrid, Spain
[3] La Paz Univ Hosp, Rheumatol, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2487
引用
收藏
页数：2
相关论文
共 50 条
  • [11] LONG-TERM OUTCOME OF ANTI-TNF THERAPY
    Sieper, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 601 - 601
  • [12] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [13] Drug survival time on anti-TNF agents: Does prior anti-TNF use influence RA outcomes?
    Kishimoto, M
    Greenberg, J
    Abramson, SB
    Harrington, T
    Olenginski, TP
    Kafka, SP
    Reed, G
    Hinkle, K
    Kremer, J
    Cohen, SB
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S347 - S347
  • [14] Depression in RA patients treated with anti-TNF is common, poorly managed and may influence anti-TNF effectiveness
    Tanveer, Wajeeha
    Hider, Samantha L.
    Brownfield, Ann
    Mattey, Derek L.
    Packham, Jon C.
    [J]. RHEUMATOLOGY, 2008, 47 : II49 - II49
  • [15] Anti-TNF alpha
    Faure, Sebastien
    [J]. ACTUALITES PHARMACEUTIQUES, 2010, 49 (500): : 51 - 54
  • [16] Anti-TNF Therapy
    Udalova, Irina
    Monaco, Claudia
    Nanchahal, Jagdeep
    Feldmann, Marc
    [J]. MICROBIOLOGY SPECTRUM, 2016, 4 (04):
  • [17] Anti-TNF therapy
    Thalayasingam, Nishanthi
    Isaacs, John D.
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (04): : 549 - 567
  • [18] Lack of response to first anti-TNFα agent should not preclude alternative anti-TNFα therapy
    Pringle, J.
    Stirling, A.
    Gordon, M. M.
    [J]. RHEUMATOLOGY, 2007, 46 : I29 - I30
  • [19] Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent
    del Carmen R-Grau, Maria
    Chaparro, Maria
    Mesonero, Francisco
    Barreiro-de Acosta, Manuel
    Castro, Luisa
    Castro, Manuel
    Domenech, Eugeni
    Mancenido, Noemi
    Lazaro Perez-Calle, Jose
    Taxonera, Carlos
    Barrio, Jesus
    De Francisco, Ruth
    Fernandez-Salgado, Estela
    Luzon, Lara
    Merino, Olga
    Oltra, Lorena
    Saro, Cristina
    Bermejo, Fernando
    Garcia-Sanchez, Valle
    Ginard, Daniel
    Gutierrez, Ana
    Vera, Isabel
    Anton, Rosario
    Ber, Yolanda
    Calvet, Xavier
    Gisbert, Javier P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 613 - 619
  • [20] Rituximab versus anti-TNF in patients who previously failed one TNF inhibitor in an observational cohort
    Chatzidionysiou, K.
    van Vollenhoven, R. F.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 190 - 195
12345